Side effects of hctz lisinopril
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Hydrochlorothiazide (HCTZ) and Lisinopril
Introduction to HCTZ and Lisinopril
Hydrochlorothiazide (HCTZ) and lisinopril are commonly prescribed medications for managing hypertension. HCTZ is a thiazide diuretic, while lisinopril is an angiotensin-converting enzyme (ACE) inhibitor. Both drugs can be used individually or in combination to achieve better blood pressure control. However, like all medications, they come with potential side effects.
Common Side Effects of HCTZ
Electrolyte Imbalance
One of the most notable side effects of HCTZ is its impact on electrolyte levels. HCTZ can cause a significant decrease in serum potassium levels, leading to hypokalemia, which can be dangerous if not monitored and managed properly Lang1991Palù1993. Additionally, HCTZ has been associated with increased plasma uric acid levels, which can exacerbate conditions like gout .
Metabolic Changes
HCTZ can also affect metabolic parameters. It has been observed to increase cholesterol levels, which could potentially contribute to cardiovascular risks Lang1991Williams1988. Moreover, HCTZ may lead to an increase in fasting glucose levels, posing a risk for patients with or at risk of diabetes .
Cardiovascular Effects
Patients treated with HCTZ have reported an increase in heart rate during short-term treatment phases . This side effect is particularly concerning for patients with pre-existing cardiovascular conditions.
Common Side Effects of Lisinopril
Electrolyte Imbalance
Lisinopril, in contrast to HCTZ, tends to increase serum potassium levels, which can lead to hyperkalemia if not monitored . This is particularly important for patients with renal impairment or those taking other medications that increase potassium levels.
Respiratory Issues
A well-documented side effect of lisinopril is a persistent dry cough, which can be bothersome enough to lead to discontinuation of the medication in some patients . This side effect is due to the accumulation of bradykinin, a peptide that can cause irritation in the respiratory tract.
Angioedema
Though rare, lisinopril can cause angioedema, a serious condition characterized by swelling of the deeper layers of the skin, often around the eyes and lips, and sometimes the throat, which can be life-threatening .
Side Effects of Combination Therapy (HCTZ and Lisinopril)
Enhanced Blood Pressure Control
The combination of HCTZ and lisinopril has been shown to be more effective in controlling blood pressure than either drug alone Kochar1987Lang1991Pool1987. However, this combination also comes with a higher incidence of side effects.
Increased Frequency of Mild Side Effects
Patients on the combination therapy reported more frequent mild side effects compared to those on monotherapy. These side effects often subsided spontaneously and included symptoms like dizziness, headache, and fatigue Kochar1987Lang1991.
Metabolic and Electrolyte Effects
The combination therapy can lead to a decrease in potassium levels due to HCTZ, while lisinopril may counteract this effect to some extent by increasing potassium levels . However, the net effect on potassium levels can vary, necessitating regular monitoring. Additionally, the combination therapy has been associated with increased plasma uric acid levels and changes in cholesterol levels Lang1991Williams1988.
Conclusion
Both HCTZ and lisinopril are effective antihypertensive agents with distinct side effect profiles. HCTZ primarily affects electrolyte balance and metabolic parameters, while lisinopril is associated with respiratory issues and, rarely, angioedema. Combination therapy offers superior blood pressure control but comes with an increased frequency of mild side effects and requires careful monitoring of electrolyte levels. Regular follow-up and monitoring are essential to manage these side effects effectively and ensure optimal therapeutic outcomes.
Sources and full results
Most relevant research papers on this topic
A 52‐Week Comparison of Lisinopril, Hydrochlorothiazide, and Their Combination in Hypertension
Lisinopril is more effective than hydrochlorothiazide as a step-one drug, and the combination of the two drugs is more effective and safer than either drug alone for controlling blood pressure.
The results of a large multicentre study comparing low-dose lisinopril-hydrochlorothiazide with the monocomponents.
Low-dose lisinopril-hydrochlorothiazide (L/HCTZ) effectively reduces blood pressure and heart rate in mild to moderate hypertensive patients, but has more side effects than lisinopril.
Treating mild-to-moderate hypertension: a comparison of lisinopril-hydrochlorothiazide fixed combination with captopril and hydrochlorothiazide free combination.
Lisinopril-hydrochlorothiazide fixed combination is a well-tolerated, once-daily treatment for mild-to-moderate hypertension with superior efficacy compared to captopril and hydrochlorothiazide free combination.
Lisinopril-hydrochlorothiazide combination vs lisinopril for the treatment of hypertension.
In patients uncontrolled on lisinopril 20 mg, switching to lisinopril-hydrochlorothiazide combination is as effective as increasing lisinopril to 40 mg once daily.
Plasma Lipid Profiles and Antihypertensive Agents: Effects of Lisinopril, Enalapril, Nitrendipine, Hydralazine, and Hydrochlorothiazide
Lisinopril, enalapril, and nitrendipine do not affect plasma lipid concentrations, while hydralazine lowers total and LDL cholesterol.
DOI